MX2021004465A - Método para proporcionar la administración subcutánea de anticuerpos anti-cd38. - Google Patents
Método para proporcionar la administración subcutánea de anticuerpos anti-cd38.Info
- Publication number
- MX2021004465A MX2021004465A MX2021004465A MX2021004465A MX2021004465A MX 2021004465 A MX2021004465 A MX 2021004465A MX 2021004465 A MX2021004465 A MX 2021004465A MX 2021004465 A MX2021004465 A MX 2021004465A MX 2021004465 A MX2021004465 A MX 2021004465A
- Authority
- MX
- Mexico
- Prior art keywords
- subcutaneous administration
- monoclonal antibodies
- methods
- daratumumab
- corticosteroid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporcionan métodos de administración subcutánea de anticuerpos monoclonales anti-CD38, tales como daratumumab; se proporcionan también métodos para el tratamiento de enfermedades autoinmunes con anticuerpos monoclonales anti-CD38 administrados por vía subcutánea. Un corticosteroide se administra opcionalmente antes de la administración subcutánea del anticuerpo anti-CD38 para prevenir y/o reducir los efectos secundarios relacionados con la inyección sistémica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862747107P | 2018-10-17 | 2018-10-17 | |
PCT/US2019/056838 WO2020081881A2 (en) | 2018-10-17 | 2019-10-17 | Method of providing subcutaneous administration of anti-cd38 antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021004465A true MX2021004465A (es) | 2021-08-24 |
Family
ID=68531583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021004465A MX2021004465A (es) | 2018-10-17 | 2019-10-17 | Método para proporcionar la administración subcutánea de anticuerpos anti-cd38. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200121588A1 (es) |
EP (1) | EP3867275A2 (es) |
JP (1) | JP2022512722A (es) |
KR (1) | KR20210077725A (es) |
CN (1) | CN113195540A (es) |
AU (1) | AU2019362868A1 (es) |
BR (1) | BR112021007227A2 (es) |
CA (1) | CA3116878A1 (es) |
MA (1) | MA53920A (es) |
MX (1) | MX2021004465A (es) |
WO (1) | WO2020081881A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
US9732154B2 (en) | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
PE20171094A1 (es) | 2014-12-04 | 2017-08-07 | Janssen Biotech Inc | Anticuerpos anti-cd38 para el tratamiento de la leucemia linfoblastica aguda |
US20170044265A1 (en) | 2015-06-24 | 2017-02-16 | Janssen Biotech, Inc. | Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 |
US10781261B2 (en) | 2015-11-03 | 2020-09-22 | Janssen Biotech, Inc. | Subcutaneous formulations of anti-CD38 antibodies and their uses |
MY202415A (en) | 2015-11-03 | 2024-04-27 | Janssen Biotech Inc | Subcutaneous formulations of anti-cd38 antibodies and their uses |
MA50514A (fr) | 2017-10-31 | 2020-09-09 | Janssen Biotech Inc | Méthodes de traitement du myélome multiple à haut risque |
EP4277930A1 (en) * | 2021-01-14 | 2023-11-22 | MorphoSys AG | Anti-cd38 antibodies and their uses |
CA3237175A1 (en) * | 2021-11-03 | 2023-05-11 | Janssen Biotech, Inc. | Corticosteriod reduction in treatment with anti-cd38 antibodies |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE87659T1 (de) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
ES2227512T3 (es) | 1991-12-02 | 2005-04-01 | Medical Research Council | Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago. |
AU690528B2 (en) | 1992-12-04 | 1998-04-30 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
US7829693B2 (en) | 1999-11-24 | 2010-11-09 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of a target gene |
EP1603541B2 (en) | 2003-03-05 | 2013-01-23 | Halozyme, Inc. | SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
JP2008504013A (ja) | 2004-02-06 | 2008-02-14 | モルフォシス・アクチェンゲゼルシャフト | 抗cd38ヒト抗体及びその用途 |
IL296666A (en) | 2005-03-23 | 2022-11-01 | Genmab As | Antibodies against 38cd for the treatment of multiple myeloma |
TW200745162A (en) | 2005-05-24 | 2007-12-16 | Morphosys Ag | Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38 |
RU2425841C2 (ru) | 2005-10-12 | 2011-08-10 | МорфоСис АГ | Получение и анализ полностью человеческих лечебных антител-производных hucal gold, специфичных к человеческому cd38 |
EP1914242A1 (en) | 2006-10-19 | 2008-04-23 | Sanofi-Aventis | Novel anti-CD38 antibodies for the treatment of cancer |
AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
MX2014005358A (es) * | 2011-11-03 | 2014-09-12 | Tolera Therapeutics Inc | Anticuerpo y metodos para la inhibicion selectiva de respuestas mediadas por celulas t. |
SG11201508923VA (en) | 2013-04-29 | 2015-11-27 | Teva Pharmaceuticals Australia Pty Ltd | Anti-cd38 antibodies and fusions to attenuated interferon alpha-2b |
US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
MA41555A (fr) * | 2015-02-17 | 2017-12-26 | Millennium Pharm Inc | Polythérapie pour le traitement du cancer |
US20170121417A1 (en) * | 2015-11-03 | 2017-05-04 | Janssen Biotech, Inc. | Subcutaneous Formulations of Anti-CD38 Antibodies and Their Uses |
KR102630475B1 (ko) * | 2015-11-30 | 2024-01-26 | 브리스톨-마이어스 스큅 컴퍼니 | 항 인간 ip-10 항체 및 이의 용도 |
MX2020010144A (es) * | 2018-03-28 | 2020-12-07 | Takeda Pharmaceuticals Co | Dosificación subcutánea de anticuerpos anti grupo de diferenciación 38 (cd38). |
-
2019
- 2019-10-17 WO PCT/US2019/056838 patent/WO2020081881A2/en unknown
- 2019-10-17 KR KR1020217014495A patent/KR20210077725A/ko unknown
- 2019-10-17 JP JP2021521036A patent/JP2022512722A/ja active Pending
- 2019-10-17 EP EP19801640.4A patent/EP3867275A2/en not_active Withdrawn
- 2019-10-17 CA CA3116878A patent/CA3116878A1/en active Pending
- 2019-10-17 BR BR112021007227-6A patent/BR112021007227A2/pt not_active Application Discontinuation
- 2019-10-17 AU AU2019362868A patent/AU2019362868A1/en not_active Abandoned
- 2019-10-17 CN CN201980083952.5A patent/CN113195540A/zh active Pending
- 2019-10-17 MX MX2021004465A patent/MX2021004465A/es unknown
- 2019-10-17 US US16/656,569 patent/US20200121588A1/en not_active Abandoned
- 2019-10-17 MA MA053920A patent/MA53920A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CN113195540A (zh) | 2021-07-30 |
WO2020081881A3 (en) | 2020-05-22 |
BR112021007227A2 (pt) | 2021-08-10 |
US20200121588A1 (en) | 2020-04-23 |
AU2019362868A1 (en) | 2021-05-13 |
MA53920A (fr) | 2021-09-15 |
KR20210077725A (ko) | 2021-06-25 |
EP3867275A2 (en) | 2021-08-25 |
CA3116878A1 (en) | 2020-04-23 |
JP2022512722A (ja) | 2022-02-07 |
WO2020081881A2 (en) | 2020-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021004465A (es) | Método para proporcionar la administración subcutánea de anticuerpos anti-cd38. | |
WO2020081630A3 (en) | Robotic animal puzzle | |
MX2019001897A (es) | Anticuerpo anti-lag-3. | |
Sawalha et al. | The use of melatonin and progestagen–eCG to initiate reproductive activity in prepuberal Awassi ewe lambs | |
JPS5283911A (en) | Fat emulsion for intravenous injection | |
Ratskiy et al. | The T-and B-cell specific immunity of calves under the influence of complex liposomal drug | |
Gabriel | A complete one-man technique for the collection of cock semen and the insemination of caged hens | |
USD169863S (en) | Toy airplane ob similar article | |
Lim et al. | Effect of hCG, LHRHa, ovaprim and pimozide on ovulation induction in long snout bullhead Leiocassis longirotris | |
USD150571S (en) | Henrichsen automobile | |
USD165075S (en) | Combined cream and sugar vessels and tray therefor | |
Al-Slyvany et al. | Effect of Vitamins A and E on Some Reproduction Parameters in the Sheep | |
USD168015S (en) | Toy animal figure or the like | |
USD147712S (en) | Design fgs an airplane control wheel | |
Al-Shuwaili | The effect of adding (Rose marinusofficinalis) and (thymus vulgaris) to broilersdiet on immuneresponse and some physiological parameters of broilers | |
Mishustina et al. | RESPIRATORY SIMULATOR OF «SAMOZDRAV», AS A METHOD OF CARRYING OUT OF HYPOCHICALLY HYPERCAPNIC TRAININGS | |
USD162766S (en) | Holder fob lipsticks ob the like | |
Goralsky et al. | The peculiarities of histoarchitectonics of liver in rabbits fed with combined feed with various chrome content | |
USD141952S (en) | Design fob a target game device | |
زيد فدعم عسل et al. | USE OF SOME OVULATION STIMULANTS IN ARTIFICIAL PROPAGATION OF COMMON CARP (CYPRINUS CARPIO L.) | |
Cao et al. | Effect of green forage on development of the reproductive organ and diversity of the gut microbiota in Meishan prepubertal gilts | |
Wu et al. | Delayed poststroke treatment with 9-cis retinoic acid improved locomotor behavior in stroke rats | |
JP1716265S (ja) | 飛行機型おもちゃ | |
Shelton | The Apology for War | |
Zhang et al. | Reducing piglet mortality by early treatment. |